review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0162-3109(00)80296-9 |
P698 | PubMed publication ID | 10904110 |
P2093 | author name string | Atkinson JP | |
Hourcade D | |||
Krych-Goldberg M | |||
Liszewski MK | |||
P2860 | cites work | Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertases | Q22010707 |
Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis | Q24294595 | ||
Decay-accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method | Q24306280 | ||
Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins | Q24312892 | ||
The human CD46 molecule is a receptor for measles virus (Edmonston strain) | Q24317745 | ||
CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes | Q24338598 | ||
Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol) | Q24527312 | ||
Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement | Q24613512 | ||
Structure of the human CR1 gene. Molecular basis of the structural and quantitative polymorphisms and identification of a new CR1-like allele | Q24682068 | ||
Identification of an alternative polyadenylation site in the human C3b/C4b receptor (complement receptor type 1) transcriptional unit and prediction of a secreted form of complement receptor type 1 | Q24682397 | ||
Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins | Q24682687 | ||
Crystal structure of two CD46 domains reveals an extended measles virus-binding surface | Q27618470 | ||
New structural motifs on the chymotrypsin fold and their potential roles in complement factor B | Q27620995 | ||
Three-dimensional structure of a complement control protein module in solution | Q27649903 | ||
Solution structure of a pair of complement modules by nuclear magnetic resonance | Q27731948 | ||
NMR studies of a viral protein that mimics the regulators of complement activation | Q27743722 | ||
X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2 | Q27757710 | ||
A new repetitive sequence uniquely present in the decay-accelerating factor genes | Q48039933 | ||
Analysis of the human regulators of complement activation (RCA) gene cluster with yeast artificial chromosomes (YACs) | Q48186548 | ||
Membrane cofactor protein (MCP, CD46) in seminal plasma and on spermatozoa in normal and "sterile" subjects | Q49142470 | ||
Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. | Q52519424 | ||
The role of complement and complement receptors in induction and regulation of immunity. | Q53992218 | ||
Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. | Q54560552 | ||
Mapping the binding domains on decay accelerating factor (DAF) for haemagglutinating enteroviruses: implications for the evolution of a DAF-binding phenotype | Q56787212 | ||
Polymorphic expression of CD46 protein isoforms due to tissue-specific RNA splicing | Q57272510 | ||
Bridging the gap by AAA ATPases | Q59063561 | ||
Trophoblast/Leukocyte-Common Antigen is Expressed by Human Testicular Germ Cells and Appears on the Surface of Acrosome-Reacted Sperm1 | Q60686957 | ||
Molecular modeling and mechanism of action of human decay-accelerating factor. | Q64945078 | ||
Ontogeny of membrane cofactor protein: phenotypic divergence in the fetal heart | Q70803288 | ||
Characterization of mouse DAF on transfectant cells using monoclonal antibodies which recognize different epitopes | Q73299170 | ||
Possible association of infertility with sperm-specific abnormality of CD46 | Q73419602 | ||
Structure-function analysis of the active sites of complement receptor type 1 | Q74424457 | ||
Molecular cloning, expression and characterization of the rat analogue of human membrane cofactor protein (MCP/CD46) | Q78197564 | ||
C3d of complement as a molecular adjuvant: bridging innate and acquired immunity | Q28272810 | ||
Solution structure of the fifth repeat of factor H: a second example of the complement control protein module | Q28279008 | ||
A 3D model for the measles virus receptor CD46 based on homology modeling, Monte Carlo simulations, and hemagglutinin binding studies | Q30176620 | ||
Sites within the complement C3b/C4b receptor important for the specificity of ligand binding | Q30454140 | ||
Viral cell entry induced by cross-linked decay-accelerating factor | Q33785545 | ||
The instructive role of innate immunity in the acquired immune response | Q34375203 | ||
Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A streptococcus | Q34472351 | ||
Measles virus and C3 binding sites are distinct on membrane cofactor protein (CD46). | Q34584708 | ||
Human complement C3b/C4b receptor (CR1) mRNA polymorphism that correlates with the CR1 allelic molecular weight polymorphism | Q34614841 | ||
Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus | Q35096691 | ||
Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). | Q35835449 | ||
Mapping of the C3b-binding site of CR1 and construction of a (CR1)2-F(ab')2 chimeric complement inhibitor | Q36230727 | ||
Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte | Q36343760 | ||
Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes | Q36347257 | ||
The role of complement component C3b and its receptors in sperm-oocyte interaction | Q36630669 | ||
Complement evasion strategies of microorganisms | Q36705669 | ||
Molecular cloning of a complementary DNA for a membrane cofactor protein (MCP, CD46)/measles virus receptor on Vero cells and its functional characterization | Q36842224 | ||
Molecular cloning of a pig homologue of membrane cofactor protein (CD46). | Q36867730 | ||
The Clearance of Immune Complexes From the Circulation of Man and Other Primates | Q37078342 | ||
Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2 | Q37652278 | ||
Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines | Q37677073 | ||
Membrane cofactor protein with different types of N-glycans can serve as measles virus receptor | Q38293491 | ||
Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46. | Q38294177 | ||
The N-glycan of the SCR 2 region is essential for membrane cofactor protein (CD46) to function as a measles virus receptor | Q38354701 | ||
Physiological and pathological aspects of circulating immune complexes | Q38620468 | ||
The regulators of complement activation (RCA) gene cluster | Q38665434 | ||
The generation of transgenic pigs as potential organ donors for humans. | Q40429984 | ||
Complement in human reproduction: activation and control | Q40804738 | ||
Membrane cofactor protein (MCP; CD46): isoform-specific tyrosine phosphorylation | Q40902413 | ||
Use of site-specific mutagenesis and monoclonal antibodies to map regions of CD46 that interact with measles virus H protein | Q40948506 | ||
Characterization of echoviruses that bind decay accelerating factor (CD55): evidence that some haemagglutinating strains use more than one cellular receptor | Q41021933 | ||
CR1 (CD35) and CR3 (CD11b/CD18) mediate infection of human monocytes and monocytic cell lines with complement-opsonized HIV independently of CD4 | Q41564765 | ||
Identification and biology of cellular receptors for the coxsackie B viruses group. | Q41593043 | ||
Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1 | Q41644730 | ||
Molecular cloning of a murine homologue of membrane cofactor protein (CD46): preferential expression in testicular germ cells | Q41999817 | ||
Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interaction | Q42942040 | ||
CD46 is a cellular receptor for human herpesvirus 6. | Q44613357 | ||
Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor | Q44935464 | ||
Mapping of the primary binding site of measles virus to its receptor CD46. | Q45760982 | ||
Measles virus recognizes its receptor, CD46, via two distinct binding domains within SCR1-2. | Q45762265 | ||
Mechanism of suppression of cell-mediated immunity by measles virus | Q45770172 | ||
Separation of self from non-self in the complement system | Q47688509 | ||
P433 | issue | 1-2 | |
P304 | page(s) | 103-116 | |
P577 | publication date | 2000-08-01 | |
P1433 | published in | Immunopharmacology | Q24031542 |
P1476 | title | Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1. | |
P478 | volume | 49 |
Q33389860 | Adenovirus capsid-display of the retro-oriented human complement inhibitor DAF reduces Ad vector-triggered immune responses in vitro and in vivo. |
Q39864028 | Adenovirus type 11 uses CD46 as a cellular receptor |
Q42638203 | Amino acid patterns within short consensus repeats define conserved duplicons shared by genes of the RCA complex |
Q39422339 | Anti-Sp17 monoclonal antibody with antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity activities against human ovarian cancer cells |
Q40338046 | Blockade of bulky lymphoma-associated CD55 expression by RNA interference overcomes resistance to complement-dependent cytotoxicity with rituximab. |
Q36756850 | Complement in immune and inflammatory disorders: pathophysiological mechanisms |
Q53942590 | Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acid. |
Q24632001 | Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases |
Q36222203 | Development of complement therapeutics for inhibition of immune-mediated red cell destruction |
Q36506856 | Dissection of functional sites in herpesvirus saimiri complement control protein homolog |
Q39644772 | Distinct CD55 Isoform Synthesis and Inhibition of Complement-Dependent Cytolysis by Hepatitis C Virus |
Q44160700 | Effects of the mycotoxin ochratoxin A and some of its metabolites on human kidney cell lines |
Q34069057 | Electrostatic modeling predicts the activities of orthopoxvirus complement control proteins |
Q37426876 | Epithelial invasion by Escherichia coli bearing Dr fimbriae is controlled by nitric oxide-regulated expression of CD55. |
Q34885229 | Expression of complement components, receptors and regulators by human dendritic cells. |
Q42639676 | Genomic analysis reveals a duplication of eight rather than seven short consensus repeats in primate CR1 and CR1L: evidence for an additional set shared between CR1 and CR2. |
Q38315657 | Hepatitis C virus infection upregulates CD55 expression on the hepatocyte surface and promotes association with virus particles |
Q35728873 | Hepatitis C virus infection: establishment of chronicity and liver disease progression |
Q28217335 | Human Herpesvirus 6 and Measles Virus Employ Distinct CD46 Domains for Receptor Function |
Q36719729 | Identification of a complement receptor 1 peptide for inhibition of immune hemolysis |
Q30447940 | Identification of complement regulatory domains in vaccinia virus complement control protein |
Q30448441 | Identification of functional domains in kaposica, the complement control protein homolog of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) |
Q42802486 | Interaction of Glycoprotein H of Human Herpesvirus 6 with the Cellular Receptor CD46 |
Q42925054 | Intermodule cooperativity in the structure and dynamics of consecutive complement control modules in human C1r |
Q37356020 | Mapping of functional domains in herpesvirus saimiri complement control protein homolog: complement control protein domain 2 is the smallest structural unit displaying cofactor and decay-accelerating activities |
Q54517081 | Melatonin attenuates inflammation and promotes regeneration in rabbits with fulminant hepatitis of viral origin. |
Q91622826 | Molecular engineering of an efficient four-domain DAF-MCP chimera reveals the presence of functional modularity in RCA proteins |
Q36179379 | Mutational analysis of Kaposica reveals that bridging of MG2 and CUB domains of target protein is crucial for the cofactor activity of RCA proteins |
Q33755215 | Pathogenesis of Afa/Dr diffusely adhering Escherichia coli |
Q39735958 | Screening of complement inhibitors: shielded baculoviruses increase the safety and efficacy of gene delivery |
Q33433754 | Self-nonself discrimination by the complement system |
Q104503342 | Sialylation acts as a checkpoint for innate immune responses in the central nervous system |
Q92513347 | Spatially conserved motifs in complement control protein domains determine functionality in regulators of complement activation-family proteins |
Q34127130 | Structure-function analysis of decay-accelerating factor: identification of residues important for binding of the Escherichia coli Dr adhesin and complement regulation |
Q39730178 | The Afa/Dr adhesins of diffusely adhering Escherichia coli stimulate interleukin-8 secretion, activate mitogen-activated protein kinases, and promote polymorphonuclear transepithelial migration in T84 polarized epithelial cells |
Q33775122 | The alternative complement pathway regulates pathological angiogenesis in the retina |
Q33908734 | Variant-specific tropism of human herpesvirus 6 in human astrocytes |
Search more.